TRCT
KIDS icon

Tower Research Capital (TRC)’s OrthoPediatrics KIDS Stock Holding History

Tower Research Capital (TRC)’s Portfolio KIDS Stock Details KIDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.7K Buy
1,864
+640
+52% +$11.1K ﹤0.01% 3031
2026
Q1 		$19.4K Sell
1,224
-1,076
-47% -$18.8K ﹤0.01% 3499
2025
Q4 		$40.8K Buy
2,300
+1,232
+115% +$21.6K ﹤0.01% 2582
2025
Q3 		$19.8K Sell
1,068
-600
-36% -$12.4K ﹤0.01% 3321
2025
Q2 		$35.8K Buy
1,668
+1,137
+214% +$24.6K ﹤0.01% 3257
2025
Q1 		$13.1K Sell
531
-1,322
-71% -$32.6K ﹤0.01% 3399
2024
Q4 		$43K Buy
1,853
+195
+12% +$4.88K ﹤0.01% 2649
2024
Q3 		$44.9K Sell
1,658
-2,216
-57% -$67.1K ﹤0.01% 2781
2024
Q2 		$111K Buy
3,874
+3,841
+11,639% +$118K ﹤0.01% 2505
2024
Q1 		$962 Sell
33
-4,408
-99% -$123K ﹤0.01% 5358
2023
Q4 		$144K Buy
4,441
+3,475
+360% +$101K ﹤0.01% 2351
2023
Q3 		$30.9K Buy
966
+165
+21% +$6.36K ﹤0.01% 2997
2023
Q2 		$35.1K Buy
801
+12
+2% +$553 ﹤0.01% 2884
2023
Q1 		$35K Sell
789
-100
-11% -$4.42K ﹤0.01% 2839
2022
Q4 		$35K Sell
889
-76
-8% -$3.17K ﹤0.01% 2611
2022
Q3 		$44K Buy
965
+68
+8% +$3.33K ﹤0.01% 3285
2022
Q2 		$39K Buy
897
+747
+498% +$34.2K ﹤0.01% 3120
2022
Q1 		$8K Sell
150
-96
-39% -$4.9K ﹤0.01% 4592
2021
Q4 		$15K Sell
246
-288
-54% -$17.9K ﹤0.01% 3996
2021
Q3 		$35K Sell
534
-397
-43% -$25.8K ﹤0.01% 3239
2021
Q2 		$59K Buy
931
+329
+55% +$18.9K ﹤0.01% 2890
2021
Q1 		$29K Sell
602
-8,839
-94% -$424K ﹤0.01% 3585
2020
Q4 		$389K Sell
9,441
-2,684
-22% -$123K 0.01% 1188
2020
Q3 		$557K Buy
12,125
+10,132
+508% +$470K 0.01% 1564
2020
Q2 		$87K Buy
+1,993
New +$89.6K ﹤0.01% 2588
2020
Q1 		– Sell
-154
Closed -$7K – 3493
2019
Q4 		$7K Buy
154
+34
+28% +$1.32K ﹤0.01% 2525
2019
Q3 		$4K Buy
+120
New +$4.16K ﹤0.01% 3422
2018
Q3 		– Sell
-140
Closed -$4K – 4015
2018
Q2 		$4K Sell
140
-3,052
-96% -$65.1K ﹤0.01% 3138
2018
Q1 		$48K Sell
3,192
-8,095
-72% -$143K ﹤0.01% 1698
2017
Q4 		$217K Buy
+11,287
New +$216K 0.03% 534

Other funds holding KIDS

Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Tower Research Capital (TRC)'s KIDS Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its OrthoPediatrics (KIDS) stake by 52% in Q2 2026, buying an estimated $11.1K and bringing the position to 1,864 shares worth $35.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3031.

Tower Research Capital (TRC) first reported a position in KIDS in Q4 2017 and has held it in 30 quarters since. The position peaked at $557K in Q3 2020. 120 funds tracked by Wall St. Rank hold KIDS as of Q2 2026.

  • Tower Research Capital (TRC) held 1,864 shares of OrthoPediatrics worth $35.7K as of Q2 2026.
  • Tower Research Capital (TRC) bought 640 OrthoPediatrics shares in Q2 2026, an estimated $11.1K.
  • OrthoPediatrics made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3031 holding.
  • Tower Research Capital (TRC) first reported a position in OrthoPediatrics in Q4 2017 and has held it in 30 quarters since.
  • Tower Research Capital (TRC)'s OrthoPediatrics position peaked at $557K in Q3 2020.
  • 120 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.